Related Experiment Video
Updated: Oct 21, 2025

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
[Emerging infectious disease and transfusion-transmitted infection]
1Kumamoto Red Cross Blood Center.
Blood transfusion safety has improved with Hepatitis E virus (HEV) and Chagas disease testing. Future efforts focus on bacterial screening and emerging infectious diseases like dengue virus (DENV) to prevent transfusion-transmitted infections.
Area of Science:
- Infectious Diseases
- Transfusion Medicine
- Public Health
Background:
- Hepatitis B, C, and HIV are historically significant transfusion-transmitted infections with declining incidence.
- Transfusion-transmitted Hepatitis E virus (HEV) infections have been reported in Japan since 2011, with five cases in 2019.
- Chagas disease is a risk associated with blood transfusion, necessitating donor screening.
Purpose of the Study:
- To review the current landscape of transfusion-transmitted infections.
- To highlight recent advancements in blood safety measures in Japan.
- To discuss future strategies for preventing emerging infectious disease transmission via blood products.
Main Methods:
- Implementation of Hepatitis E virus (HEV) antibody testing for blood donors.
- Introduction of Trypanosoma cruzi antibody testing for selective blood donors.
- Ongoing surveillance and preparedness for emerging infectious diseases.
Main Results:
- HEV antibody testing for all blood donors initiated in August 2020 is expected to reduce transfusion-transmitted HEV.
- Trypanosoma cruzi antibody testing, implemented in August 2016, has decreased the risk of Chagas disease transmission.
- The focus is shifting towards comprehensive screening and proactive measures against novel pathogens.
Conclusions:
- Recent screening initiatives have significantly enhanced blood product safety in Japan.
- Continuous vigilance, including bacterial testing and monitoring of global emerging infectious diseases (e.g., DENV, WNV, Zika, CHIKV), is crucial.
- Proactive development of testing protocols and donor eligibility criteria for emerging threats is essential for future transfusion safety.
Related Concept Videos
Sexually Transmitted Infections
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Endocarditis I: Introduction

